US 9168262
Estriol therapy for multiple sclerosis and other autoimmune diseases
granted A61KA61K31/56A61K31/565
Quick answer
US patent 9168262 (Estriol therapy for multiple sclerosis and other autoimmune diseases) held by The Regents of the University of California expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/56, A61K31/565, A61K31/57, A61K31/573